Antibodies binding CD40 and uses thereof
AssigneeBiosion Inc.
InventorsMark Zhiqing Ma, Jinyu Liu, Zhengping Zhang, Hongjiang Xu
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiosion Inc.
InventorsMark Zhiqing Ma, Jinyu Liu, Zhengping Zhang, Hongjiang Xu
Estimating the term…
Provided is an isolated monoclonal antibody or an antigen-binding portion thereof that specifically binds human CD40. A nucleic acid molecule encoding the antibody or antigen-binding portion thereof, an expression vector, a host cell and a method for expressing the antibody or the antigen-binding portion thereof are also provided. An immunoconjugate, a bispecific molecule, a chimeric antigen receptor, an oncolytic virus and a pharmaceutical composition comprising the antibody or antigen-binding portion thereof, as well as a treatment method using the same are further provided.
An isolated monoclonal antibody or an antigen-binding portion thereof, capable of binding to CD40, comprising (i) a heavy chain variable region comprising a VH CDR1 region, a VH CDR2 region and a VH CDR3 region, and (ii) a light chain variable region comprising a VL CDR1 region, a VL CDR2 region and a VL CDR3 region, wherein the VH CDR1 region, the VH CDR2 region, the VH CDR3 region, the VL CDR1 region, the VL CDR2 region and the VL CDR3 region comprise amino acid sequences set forth in (1) SEQ ID NOs:
Dependencies are inferred from the claim text.